Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer

BACKGROUND: Prostate cancer remains the second leading cause of cancer related death in men. Immune check point blocking antibodies have revolutionized treatment of multiple solid tumors, but results in prostate cancer remain marginal. Previous reports have suggested that local therapies, in particu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Prostate Cancer Prostatic Dis
Autores principales: Benzon, Benjamin, Glavaris, Stephanie A., Simons, Brian W., Hughes, Robert M., Ghabili, Kamyar, Mullane, Patrick, Miller, Rebecca, Nugent, Katriana, Shinder, Brian, Tosoian, Jeffrey, Fuchs, Ephraim J., Tran, Phuoc T., Hurley, Paula J., Vuica-Ross, Milena, Schaeffer, Edward M., Drake, Charles G., Ross, Ashley E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5990963/
https://ncbi.nlm.nih.gov/pubmed/29556048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41391-018-0035-z
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares